Cargando…
How Should We Assign Large Infiltrative Hepatocellular Carcinomas for Staging?
SIMPLE SUMMARY: The outcome of hepatocellular carcinoma (HCC) patient varies depending on tumor burden and liver function. The BCLC staging system is based on these two factors while AJCC staging system is based on tumor burden only. However, the outcome of HCC does not solely depend on these two fa...
Autores principales: | Lee, Yoo Jin, Lee, Yoo Ra, Seo, Chung Gyo, Goh, Hyun Gil, Kim, Tae Hyung, Yim, Sun Young, Han, Na Yeon, Lee, Jae Min, Choi, Hyuk Soon, Kim, Eun Sun, Keum, Bora, An, Hyonggin, Park, Beomjin, Seo, Yeon Seok, Yim, Hyung Joon, Kim, Ji Hoon, Yu, Young Dong, Kim, Dong Sik, Jeen, Yoon Tae, Chun, Hoon Jai, Lee, Hong Sik, Kim, Chang Duck, Um, Soon Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564178/ https://www.ncbi.nlm.nih.gov/pubmed/32927918 http://dx.doi.org/10.3390/cancers12092589 |
Ejemplares similares
-
The HBV DNA cutoff value for discriminating patients with HBeAgnegative chronic hepatitis B from inactive carriers
por: Kim, Eun Sun, et al.
Publicado: (2011) -
Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients
por: Yim, Sun Young, et al.
Publicado: (2017) -
Serum cystatin C level is a useful marker for the evaluation of renal function in patients with cirrhotic ascites and normal serum creatinine levels
por: Kim, Dong Jin, et al.
Publicado: (2011) -
Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B
por: Kim, Tae Hyung, et al.
Publicado: (2018) -
Comparison of 2 curative treatment options for very early hepatocellular carcinoma: Efficacy, recurrence pattern, and retreatment
por: Kim, Tae Hyung, et al.
Publicado: (2019)